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1 Introduction  
 
Pain is a troublesome sensation associated with actual or potential damage and acts as a 
defense mechanism against potential and actual stimuli, which is crucial to our survival 1. 
Pain was initially recognized as only a symptom, only for this belief to change later when it 
was realized that in a vast number of affected people there are no structural abnormalities or 
morphological changes which might cause this pain 2. Certain features of pain have long 
puzzled clinicians and researchers, but the remarkable progress of pain research in the last 
decade has provided us with valuable insights into pain etiologies, signal transmission and 
underlying mechanisms 3,4. Nonetheless, pain remains the primary reason for patients seeking 
health care 5.  
 
1.1 Classification of pain 
 
In order to establish a framework for standardized diagnostic procedures and potential 
therapeutic approaches, pain may be categorized by etiology (e.g. cancer pain), perceived 
location (e.g. orofacial pain) or affected anatomical system (e.g. neuropathic pain). Severity 
and duration of pain are decisive features that distinguish acute and chronic pain. Acute pain 
is usually characterized by sudden onset with short duration, whilst chronic pain is defined as 
pain that persists beyond the reasonable healing time for a specific injury 6. 
A Task Force initiated by the International Association for the Study of Pain (IASP) and the 
World Health Organization (WHO) revised the current definition of chronic pain to 
complement the current version of the International Classification of Diseases (ICD 11) 7. 
This new classification defined chronic pain as “pains that occur on at least 50% of the days 
during at least 3 months” replacing the former definition set by the IASP of six-month 
duration. This classification includes 7 groups, (1) chronic primary pain, (2) chronic cancer 
pain, (3) chronic posttraumatic and postsurgical pain, (4) chronic neuropathic pain, (5) 
chronic headache and orofacial pain, (6) chronic visceral pain and (7) chronic musculoskeletal 
pain.  
This pragmatic and clinically applicable classification is based on the “multiple parenting” 
principle, which allows the same diagnosis to be listed under one category as “primary 
parent” but will be “cross-referenced” to other categories as “secondary parents”. For 
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example, temporomandibular disorders pain could be considered a primary type of pain, but is 
also a musculoskeletal pain and clearly one of the subsets of orofacial pain.  
 
1.2 Orofacial pain  
 
The American Academy of Orofacial Pain (AAOP) defines orofacial pain as pain around the 
eyes, above the neck and anterior to the ears as well as pain within the mouth 8. Orofacial pain 
is considered an umbrella term that includes various subsets such as: masticatory 
musculoskeletal pain, pain related to temporomandibular joint disorders, intra-oral and dental 
diseases.  
It has been reported that around 3.5 billion patients have untreated intraoral and dental 
diseases 9. A predicted biological consequence of untreated dental diseases is pain. 
Epidemiologic data have reported that up to 45% of the population suffer of orofacial pain 
and up to 27.5% of its intraoral subset 9-11. Compared to other pain categories, studies looking 
into intraoral and dental causes of orofacial pain have been less rigorous, with the exemption 
of pain related to temporomandibular disorders, leaving us with little or no data on other 
etiologies 12,13.  
Due to the complexity of the region, diversity of underlying anatomical structures and 
unpredictable pain referral mechanisms, an accurate diagnosis and proper management of 
orofacial pain disorders may present a difficult challenge for the physician 14. Some severe 
cases require a thorough examination, adequate imaging and may even call for a 
multidisciplinary approach involving a neurologist, an otolaryngologist and a dentist.  
The role of dentists in treating orofacial pain remains often neglected by patients who tend to 
seek treatment from medical practitioners first 15. Pain of dental origin may start as a short 
stabbing pain but can also progress to persistent dull pain based on its etiology. A key point in 
orofacial pain diagnosis is to inspect and rule out all possible underlying causes, which may 
refer the pain to other regions distant from the origin 16. 
 
1.3 Third molars and associated pathologies: 
 
Pain accompanying tooth eruption is familiar during the primary dentition stage. Such 
complaints are also quite common during the permanent dentition stage particularly around 
third molars as they are the last erupting and most frequently impacted teeth in humans 
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between the age of 17-21 years 17,18. This condition is known as pericoronitis, which 
manifests as an inflammation, pain and swelling of the soft tissues surrounding the crown of a 
partially erupted tooth, including the gingiva and the dental follicle 19.  
Tooth impaction is defined as an abnormal condition in which the tooth fails to erupt to its 
functional position. The incidence of impacted third molars varies enormously among 
populations from 10-70% with most studies suggesting that females have a higher incidence 
of impaction when compared to males 20,21. The population-based study of health in 
Pomerania (SHIP) showed that 16.7% of the population in Northeastern Germany has at least 
one impacted third molar 22. Possible reasons behind the impaction of third molars include 
lack of space, abnormal position and modern human diet 23.  
It has been a common belief that third molars are linked to multiple pathologies in the oral 
cavity including caries, periodontal damage of the second molar, root resorption of adjacent 
tooth and cystic changes 24,25. Some severe cases may even lead to compromised general 
health condition that requires hospitalization. Removal of impacted third molars is a common 
procedure in oral surgery. The decision to carry out this surgery should be based on a valid 
indication and must be the result of a comprehensive clarification of the patient including 
possible complications of the surgery. Despite the fact that third molars removal has been a 
standard procedure in dentistry for decades, there are no clear-cut on its spectrum and 
indications and the debate about the prophylactic removal of asymptomatic and pathology-
free third molars still exist 26,27. Advocates of prophylactic removal call for an early surgical 
removal to avoid such complications, whilst other physicians call this procedure a “public 
hazard” and claimed that up to 60% of the patients had their third molars removed for no 
valid reason 28.  
This topic has been extensively discussed in the literature and summed up as well-established 
guidelines and indications for the removal of symptomatic third molars. However, these 
guidelines have a grey zone when it comes to association of pain and third molars in the 
absence of typical pathological symptoms and call for individual risk-benefit assessment. This 
has led to conflicting opinions among experts of the same discipline when presented with the 
same cases 29.  
With little evidence-based reports, this scientific debate did not reach its goal of establishing 
consensus guidelines. For example, the German national guidelines for surgical removal of 
third molars updated in August 2019 “recommend” removing third molars in patients 
suffering atypical orofacial pain when an association can be found. Furthermore, a Cochrane 
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review published in 2016 found no evidence to support removal of asymptomatic third molars 
and called for further studies on a larger scale to prove this association 30.   
 
1.4 Rationale and objectives 
 
Patients with a pain complaint seek help at the dentist office on daily basis. The tremendous 
progress in understanding pain mechanisms from molecular-level findings to chair-side 
experiences has helped a vast number of patients overcome their pain. Nonetheless, the 
association of third molars and orofacial pain remains vague and questionable with no 
supporting representative studies.  
This epidemiological study sheds the light on an important topic that has been long speculated 
but not truly examined. Our aim is to define the association of third molars with orofacial pain 
in a representative sample from Northeastern Germany. Furthermore, results of this study may 
be a valuable contribution to the current national German guidelines for surgical removal of 






















2 Materials and Methods 
 
2.1 Study sample 
 
We analyzed whole body magnetic resonance images (MRI) from the study of health in 
Pomerania (SHIP) 31. 2333 participants took part in the 11-years follow-up examination 
(SHIP-2) and a new cohort (SHIP-Trend) included 4420 participants. All 6753 participants 
underwent a medical examination, an oral health examination, a health-related interview and a 
self-administered health- and risk factor-related questionnaire, whereby 2522 participants 
agreed to undergo an additional whole-body MRI examination 32. Due to image artifacts in 
the head region, 40 images were excluded. Further exclusion criteria included participants 
taking NSAIDs (n = 212), opioids (n = 18) or analgesics (n = 108), as well as participants 
describing pain upon palpation of the lateral condyles, in dorso-cranial direction or upon 
palpation of the masticatory muscles (n = 336) resulting in a study sample of 1808 
participants (Figure 1).  
 
 
Figure 1. Flowchart of study population 
 
- Medical examination 
- Oral health examination 
- Health-related interview  
- Self-administered health- and risk factor-related questionnaire 
4231 participants declined to undergo whole-body MRI 
Data on third molars status from 2522 participants available  
1808 participants 
Exclusion criteria:  
- Artifacts on MR images (n= 40) 
- Medication: NSAIDs (n = 212), opioids (n = 18) or 
analgesics (n = 108) 
- Pain upon palpation of the joint and masticatory muscles 
(n = 336) 
6753 participants (2333 SHIP-2, 4420 SHIP-Trend) 
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2.2 MRI acquisition and third molars analysis  
 
Magnetic resonance imaging scans were acquired using a 1.5T system (Magnetom Avanto; 
Siemens Medical Solutions). We used transversal T1-weighted turbo spin echo images (TE: 
11 ms, TR: 587 ms, slice thickness: 4 mm, matrix: 256 × 256) and sagittal T1-weighted turbo 
spin echo images (TE: 120 ms, TR: 6760 ms, slice thickness: 4 mm, matrix: 448 × 448) to 
evaluate third molars status (Figure 2, 3).  
MRI images were then examined by two trained dentists and third molars were classified 
according to Pell and Gregory as 1. missing, 2. erupted if its occlusal plane was above the 
cervical line of the adjacent second molar, 3. impacted if the occlusal plane was below the 
cervical line of the second molar. Inter-observer agreement was 98.5% for the impaction of 
third molars. Inter-observer agreement for third molars in the maxilla was a little higher (κ: 
















2.3 Pain variables 
 
Chronic orofacial pain was analyzed using a self-assessment questionnaire. Participants 
answered the question: ‘Have you experienced any facial pain, masticatory muscle pain, pain 
in the temporomandibular joint or around the ears in the last 6 months?’ as well as migraine 
or other types of headaches.  
Acute pain was inspected by palpating the masseter and temporalis muscles under pressure of 
about 1 kg/cm2 bilaterally. TMD pain was defined as pain upon lateral and dorso-cranial 





2.4 Statistical analysis  
 
Stratified by third molar status, categorical data were described as absolute numbers and 
percentages and continuous data as median, 25th and 75th percentile. Associations between 
third molar status and orofacial pain were analyzed by multivariable logistic regression 
models adjusted for age, gender, educational status and preferred chewing side.  
‘Erupted third molars’ were used as the reference category for calculation of the odds ratios. 
In all analyses, a P value <.05 was considered as statistically significant. All analyses were 




























3 Results  
 
The incidence of impacted third molars was higher among younger participants. A total of 
16% of all participants had at least one impacted third molar (n = 299), and 37.2% (n = 672) 
had no third molars at the time of examination. Higher impaction rates of third molars were 
observed in males than females for upper and lower jaw. In contrast, females had more 
missing third molars than males.  
Impacted third molars in the maxilla are associated with orofacial pain (odds ratio 2.19; 95% 
confidence interval 1.19-4.02) (Figure 4, 5), whereas there was no such association for 
impacted third molars in the mandible (odds ratio 1.33; 95% confidence interval 0.74-2.37) 
(Figure 6). This association was more evident in the right upper jaw independent of age, 
gender, level of education and preferred chewing side. On the other hand, no significant 
associations of third molar status with migraine or other types of headaches were found. 
There were no significant interactions of age or gender with impacted or missing third molars 
on orofacial pain. We included caries and periodontal diseases as confounders in our analysis 





















Our results revealed a relatively strong association between impacted third molars and 
orofacial pain in a population-based sample. Furthermore, no association between third 
molars and migraine or other types of headaches was found. Despite the remarkable growth of 
knowledge and published research on orofacial pain and its etiologies, we found no studies 
that looked into this particular association.  
Pain research has provided us with multiple classifications and standardized diagnostic 
procedures for a successful treatment through identification of biomarkers, pain mechanisms 
and risk factors. Woolf et al. published a prominent paper in 1998 where he categorized pain 
by its mechanism into: nociceptive, inflammatory, neuropathic and functional pain 33. This 
categorization simplifies complex and multifactorial procedures that might overlap and cause 
pain. Etiologies of nociceptive and inflammatory pain are fundamentally different but both 
can offer plausible explanations of our results. 
Nociception is our nervous system’s response towards actual or potential harmful stimuli, 
which activates our sensory endings known as nociceptors 34. The main responsible 
nociceptors are the Ad and C-fibers. Ad-fibers are the smallest myelinated nerves and have a 
relatively fast conduction velocity of 30 m/s and respond to thermal or mechanical stimuli. 
Such pain is perceived as sharp or stabbing pain similar to the one accompanying a partially 
erupting tooth. On the other hand, C-fibers are unmyelinated and have a relatively slow 
conduction velocity of approximately 2 µm/s and are stimulated by thermal, mechanical or 
chemical stimuli, which results in poor localization and dull pain sensation, a common feature 
among orofacial pain sufferers. Both fibers are mostly found in superficial organs such as the 
skin. However, C-fibers are additionally found in deeper organs such as the muscles and 
joints 35.  
Over the last few decades, a variety of hypotheses have been put forward to explain the 
increasing rate of third molars agenesis and impaction in humans and some genetic loci were 
speculated to play a role 36,37. We believe that impacted third molars might be perceived as 
potentially harmful stimuli, activating the nociceptors in the surrounding tissues and causing 
orofacial pain.  
Inflammation is our tissues’ response towards harmful stimuli 38. This response induces the 
release of local chemical mediators, which in turn activate the nociceptors within the inflamed 
area 35. Pericoronitis, periodontal damage and cystic changes might be considered as triggers 
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for inflammatory pain. The impact of gender on the incidence of pericoronitis has been 
largely discussed with conflicting results among populations 17. Such variations were linked 
to treatment-seeking behavior and barriers to dental-care. On the other hand, inflammation of 
periodontal tissues in the third molars region can be difficult to eliminate properly and 
requires multiple therapy sessions 22. A pervious study, of the same sample, published by our 
workgroup found no association between third molars and serum levels of inflammatory 
parameters 39. Nevertheless, locally released chemical mediators might be just enough to 
trigger an action potential, subsequently causing inflammatory pain.  
Our perceived results, in line with Woolf’s approach, have a direct clinical implication in 
which the pain management strategy is aimed at eliminating the cause of pain, i.e. treatment 
of local inflammation induced by third molars or surgical removal of impacted third molars.  
No association of mandibular third molars with orofacial pain was found, which might be due 
to morphological factors and anatomical differences between the maxilla and mandible such 
as bone type and vascularization 40. Vascular supply of the bone has been intensively 
examined especially in the orthopedic field. High vascularity is linked to higher 
concentrations of nerve growth factor and local cytokines, which in turn have been reported to 
be essential to develop pain hypersensitivity 41. We believe that the porous nature of the 
maxilla, especially in the tuberosity region, and its higher vascularity, compared to the 
mandible, facilitates the sensation and spread of pain, suggesting plausible justifications for 
our results.   
Pain referral is common among pain patients and can be defined as the site of pain being 
different from the source of pain, which usually complicates the diagnosis procedure. The 
International Classification of Headache Disorders considered partially impacted third molars 
to be among the most common causes of orofacial pain, which may refer the pain to the head 
42.  
In light of the previous findings, it is important to remember that the perceived site of pain is 
a result of complicated underlying neurophysiological mechanisms such as activated 
peripheral receptors, neurotransmitters release and transmission and projection of nociceptive 
information into the central nervous system. In our case, pain caused by impacted third molars 
can be reported by the patient in other distant areas of the head and face.  
It is not possible to identify which currently asymptomatic third molars will become 
symptomatic later. Unfortunately, the definition of symptomatic third molars is mostly limited 
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to local periodontal damage, root resorption, cysts and caries. A desired management 
approach is the watchful monitoring of third molars.   
TMD pain and masticatory muscle pain are other critical factors that might overlap with 
orofacial pain and divert the diagnosis procedure 43. Signs and symptoms of TMD can mimic 
those due to third molars in their perceived location. This might lead to unnecessary 
extractions of third molars when thought to be the cause of pain. Therefore, physicians are 
advised to perform a thorough and comprehensive oral examination including an assessment 
of the temporomandibular apparatus before setting their definitive diagnosis and therapy 
approach 44. The diagnostic criteria for TMD (DC/TMD) provides a comprehensive 
assessment for TMD pain and should be considered as the golden standard while investigating 
the cause of orofacial pain. On the other hand, several studies reported an association of 
previous third molar removal and development of TMD signs and symptoms 45. Plausible 
explanation is likely the long surgery duration requiring the patient to open their mouth 
widely for extended periods resulting in stretched muscles and ligaments, subluxation or disk 
displacement. Such complications are often overlooked in comparison to more immediate 
complications such as nerve injury and jaw fractures. This particular aspect must be 
accounted for when making risk-benefit-assessment for each individual patient suffering of 
orofacial pain.  
On a final note, while some studies reported higher pain sensitivity among females with a 
female-to-male ratio of 4:1 for some types of headaches, we found no interactions of gender 
with impacted or missing third molars on orofacial pain or other types of headaches, 
conflicting other studies 46. A possible aspect to consider is the differences in the perception 
of pain between genders, where some studies suggested higher self-reported pain among 
women 47 . Despite the pathophysiology behind this discrepancy still being unclear and 
complex, most studies linked higher pain perceptions with hormonal modulation of pain. Data 
on the association of pain with hormones’ level and its magnitude are inconsistent and need 
further investigations.  
The findings of this study set a starting point for future large-scale projects with more focus 








This study revealed a relatively strong association between impacted third molars and 
orofacial pain in a population-based sample, which has high clinical relevance. Epidemiologic 
data have reported that up to 45% of the population suffer from orofacial pain. People 
experiencing orofacial pain were 12 times more likely to report functional disability in their 
daily activities than their pain-free counterparts, thus posing a huge burden on the economical 
and health-insurance systems.  
Patients suffering from orofacial pain are best managed in multidisciplinary centers where a 
team including dentists, neurologists and pain specialists can work together considering those 
results and employing them into developing novel treatment concepts. Decisions made by 
clinicians regarding removal of third molars should be evidence-based, rather than influenced 
by personal believes and biases.   
The stimulation of pain from an impacted third molar, a normally non-painful stimulus, still 
needs further explanation to reach our ultimate goal of efficient and rationale management of 
the orofacial pain patient. 
Our results suggest that impacted third molars, especially in the upper jaw, must be 
considered as a possible reason for orofacial pain and integrated into current national and 
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Abstract
Objectives: To examine the association between third molars and orofacial pain. We 
hypothesized that impacted third molars are a cause of orofacial pain.
Methods: Magnetic resonance images of 1808 participants from two population-
based cohorts from Northeastern Germany were analysed to define the status of 
third molars according to the Pell and Gregory classification. A self-reported ques-
tionnaire and a clinical dental examination were used to detect chronic and acute 
complaints of orofacial pain, masticatory muscle pain, migraine and other types of 
headache. Logistic regression models were used to analyse the associations between 
third molar status and orofacial pain.
Results: Individuals with impacted third molars in the maxilla had a higher chance of 
chronic orofacial pain than those with erupted third molars (odds ratio 2.19; 95% CI 
1.19-4.02). No such association was detected for third molars in the lower jaw. Third 
molars were not associated with masticatory muscle pain, migraine or other types of 
headache.
Conclusions: Impacted maxillary third molars might be a cause of chronic orofacial 
pain. Thus, physicians should consider the eruption/impaction status of third molars in 
their decision-making process when treating patients who complain of orofacial pain.
K E Y W O R D S
epidemiologic studies, magnetic resonance imaging, orofacial pain, third molar, whole-body 
imaging
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1  | INTRODUC TION
Pain is a crucial reaction against chemical, physical or harmful stimuli. 
Some severe cases require a thorough examination, adequate imaging 
and may even call for a multidisciplinary approach.1 There are several 
ways to categorize pain, such as by cause (eg cancer pain), location 
(eg orofacial pain) or affected anatomical system (eg neuropathic pain). 
The intensity and nature of pain can be used to differentiate between 
acute and chronic pain. The International Association for the Study 
of Pain (IASP) and the World Health Organization (WHO) created a 
Task Force to complement the current version of the International 
Classification of Diseases (ICD 11) in respect of chronic pain. It defined 
chronic headache and orofacial pain as ‘Pains that occur on at least 
50% of the days during at least 3 months’.2 Orofacial pain is defined as 
pain of the hard and soft tissues around the eyes or ears, as well as pain 
within the oral cavity.3 It is a broad term that encompasses multiple 
subsets such as masticatory musculoskeletal pain, pain related to tem-
poromandibular joint disorders, neuropathic pain, neurovascular pain, 
intra-oral and dental diseases,4 which justifies the rapidly growing role 
of dentists in treating orofacial pain. Orofacial pain is relatively com-
mon, affecting up to 45% of the adult population, but barely half of 
those seek treatment.5-7 It can arise from different tissues and aetiol-
ogies; masticatory muscle pain and temporomandibular joint disorders 
(TMD) are examples of pain originating from soft and hard tissues, 
respectively. Previously published studies focused on orofacial pain 
related to those conditions with considerable variation of reported 
numbers,8,9 which were often justified by the different coping abilities 
and treatment seeking behaviour among populations.10,11 Additionally, 
there are numerous dental diseases that can cause orofacial pain 
which can originate from the teeth, the surrounding periodontium, 
oral mucosa and other structures of the oral cavity.12
It has long been speculated that third molars contribute to head-
ache disorders and orofacial pain.13 They are the most frequently 
impacted teeth, and many are associated with cystic changes (up to 
50% in some studies), periodontal damage (impacted third molars 
increased the risk more than 4-fold) and caries of the distal surface 
of second molars (up to 12%).14-16 There are conflicting estimates of 
the frequency of neoplastic lesions associated with third molars,17-19 
thus casting doubts on claims of necessity to remove third molars to 
prevent pathological changes.20,21 This has led to opposing opinions 
among oral surgeons and general dentists on the indications for third 
molar removal when presented with periapical radiographs of the 
same patient.22 Although this topic has been extensively discussed 
in the literature and summarized as well-established guidelines,23 
the need for third molar removal is still debated. The International 
Classification of Headache Disorders viewed partially impacted 
third molars as among the most common causes of orofacial pain.13 
A 2016 Cochrane review which investigated the need for removal of 
asymptomatic impacted third molars found no evidence to support it 
and called for longer-term studies to clarify this matter.24 The review 
defined third molars to be asymptomatic when signs of diseases af-
fecting the tooth and nearby structures, such as root resorption and 
periodontitis, were absent, and there was no mention of a possible 
association with orofacial pain. Dogan et al25 examined radiographs 
from 832 military recruits finding partially erupted third molars to 
be the most symptomatic. An investigation of orofacial pain and a 
history of third molar removal suggested that a history of third molar 
extraction is associated with orofacial pain.26 There is little in the 
literature revealed on the association of impacted or erupted third 
molars with orofacial pain. Previous studies have restricted their 
assessment to local symptoms specifically caused by partially im-
pacted third molars. Anatomical proximity means that pain caused 
by TMD can also mislead clinicians, and this was not accounted for in 
previous studies. Furthermore, recruiting patients from healthcare 
facilities compromises the generalizability of study findings.
Despite advances in understanding pain mechanisms and refer-
ral, the association between third molars and orofacial pain remains 
largely overlooked with knowledge based on limited data. Responding 
to these shortcomings, the present study aims to shed more light upon 
this association in a large representative sample of the population. We 
employed state-of-the-art MRI assessments to examine the status of 
third molars, and we assessed pain complaints through self-reported 
questionnaires augmented with oral clinical examinations to identify 
potential causes of orofacial pain. We hypothesized that individuals 
with impacted third molars have higher rates of orofacial pain.
2  | METHODS
We included participants from the Study of Health in Pomerania 
(SHIP), a cross-sectional population-based study assessing the prev-
alence and incidence of common population-relevant diseases and 
their risk factors in Northeastern Germany.27 SHIP participants were 
randomly selected using public registries. Baseline examinations 
(SHIP-0) were conducted between 1997 and 2001, at which 4308 
individuals participated. Follow-up examinations were undertaken at 
5 years (SHIP-1; 2002-2006; 3300 follow-up participants, follow-up 
response 83.6%) and 11 years (SHIP-2; 2008-2012; 2333 follow-up 
participants, follow-up response 62.9%) after baseline.27 In 2008, a 
new cohort (SHIP-Trend; 2008-2012) with 4420 participants was 
established in the same geographic region. Participants in both co-
horts underwent a medical examination, an oral health examination, 
a health-related interview and a self-administered health- and risk 
factor-related questionnaire. Out of 6753 participants from both 
SHIP-2 and SHIP-trend, a total of 2522 participants (37.3%) agreed 
to undergo an additional whole-body MRI examination. Of those 
2522 participants, 40 were excluded due to artefacts affecting the 
head region, resulting in MRI data on third molars from 2482 partici-
pants (98.4%). Excluded from this study were those taking NSAIDs 
(n = 212), opioids (n = 18) or analgesics (n = 108). Furthermore, to 
avoid confusion with signs of TMD, participants describing pain upon 
palpation of the lateral condyles, in dorso-cranial direction or upon 
palpation of the masticatory muscles were also excluded (n = 336) 
resulting in a study sample of 1808 participants (71.7%).
Magnetic resonance imaging scans used a 1.5T system (Magnetom 
Avanto; Siemens Medical Solutions). The complete whole-body MRI 
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protocol has been described previously.28 For the evaluation of third 
molars, transversal T1-weighted turbo spin echo images (TE: 11 ms, 
TR: 587 ms, slice thickness: 4 mm, matrix: 256 × 256) and sagittal 
T1-weighted turbo spin echo images (TE: 120 ms, TR: 6760 ms, slice 
thickness: 4 mm, matrix: 448 × 448) were used. Additionally, coronal 
T2-weighted fat suppressed images (TR 4891 ms, TE 670 ms, inversion 
time 160 ms, slice thickness 5 mm) were available for further analysis 
of third molars. MR images were transferred to a working station (iMac 
27″; Apple) where an open-source DICOM viewer (OsiriX v.3.8.1; 
Pixmeo) was used to load and analyse the MRI images (Figure S1).
Magnetic resonance imaging data were visually scrutinized by two 
trained dentists with a predefined Kappa algorithm used to measure 
inter-observer agreement; this was 98.5% for the impaction of third 
molars. Inter-observer agreement for third molars in the maxilla was a 
little higher (κ: .90-.94) than in the mandible (κ: .81-.83). Third molars 
were identified on the images and categorized according to Pell and 
Gregory29 as missing, erupted or impacted. A third molar was consid-
ered erupted if its occlusal plane was above the cervical line of the 
adjacent second molar. Third molars with an occlusal plane below the 
cervical line of the second molar were considered impacted.14
Study and examination protocols were approved by the ethics com-
mittee at the University Medicine Greifswald (15.05.2008, BB 39/08). 
All participants signed an informed consent form, and investigations 
were undertaken in accordance with the Declaration of Helsinki.
Data on chronic orofacial pain were collected using a self-as-
sessment questionnaire. Participants answered the question: ‘Have 
you experienced any facial pain, masticatory muscle pain, pain in the 
temporomandibular joint or around the ears in the last 6 months?’ 
They were further asked whether they had had migraine or other 
types of headache. Additionally, the masseter and temporalis mus-
cles were palpated under pressure of about 1 kg/cm2 bilaterally 
during an oral clinical examination, allowing an objective evaluation 
of acute masticatory muscle pain. We determined TMD pain using 
lateral and dorso-cranial palpation of the condyles. The lateral palpa-
tion of the TMJ was conducted with lateral pressure of about 2 kg/
cm,2 while the mouth was slightly open. The dorso-cranial condyle 
compression occurred with the participant's mandible in the relaxed 
position. Participants were asked to describe their perception as 
‘painless’, ‘uncomfortable’ or ‘painful’. To distinguish pain and dis-
comfort, each outcome (TMD pain and muscle pain) was defined as 
present if there was at least 1 site with pain upon palpation. The 
category ‘uncomfortable’ was not excluded but coded as ‘painless’. 
This examination was part of the oral examination of the SHIP study 
and was performed by 8 trained, calibrated and certified dentists.30 
Examiners' training took place before the study started and twice a 
year during data acquisition. Inter-examiner variability for TMD signs 
was measured in 5 calibrated sessions using a total of 22 volunteers 
(7 of them with functional complaints). Kappa values for detect-
ing tenderness upon palpation of the masticatory muscles and the 
temporomandibular joint ranged from 0.53 to 0.63. Training of the 
dentists and consensus discussions occurred before the start of the 
examinations and were repeated for calibration twice a year during 
the period of data collection.31
2.1 | Oral clinical examination
Coronal caries status was recorded as overt carious defects, fill-
ings, secondary caries or missing teeth recorded at surface level 
(occlusal, mesial, distal, vestibular and oral) on a half-mouth basis 
excluding third molars. Coronal caries was identified visually using 
a periodontal probe according to the WHO criteria, but excluding 
third molars.32 Using this information, the DFS scores were cal-
culated. Periodontal examinations used a half-mouth approach on 
the left or right side (SHIP-2: alternatingly assigned; SHIP-Trend: 
randomly assigned), excluding third molars. Oral examinations 
used a half-mouth approach due to limited examination time per 
participant. Probing depth (PD) and clinical attachment loss (CAL) 
were measured with a periodontal probe (SHIP-2: PCP11, SHIP-
Trend-0: PCP15; Hu-Friedy) at four sites per tooth (distobuccal, 
mesiobuccal, midbuccal and midpalatal/midlingual). Demographic 
data (ie gender and level of education), preferred chewing side and 
having a medical diagnosis of migraine, were reported through a 
computer-assisted interview.
2.2 | Statistical analysis
Stratified by third molar status, categorical data were described as 




th percentile. Associations between third molar status 
and orofacial pain were analysed using cross-tabulation logistic re-
gression models, adjusted for age, gender, educational status and 
preferred chewing side. ‘Erupted third molars’ were used as the ref-
erence category for odds ratios. In all analyses, a P value <.05 was 
considered as statistically significant. All analyses were carried out 
with Stata 15.1 (Stata Corporation).
3  | RESULTS
Younger participants had more impacted third molars than their 
older peers (Table 1). A total of 16% of all participants had at least 
one impacted third molar (n = 299), and 37.2% (n = 672) had no 
third molars at the time of examination. Higher impaction rates of 
third molars were observed in males than females for upper and 
lower jaw. In contrast, females had more missing third molars than 
males.
We detected an association between impacted third molars in 
the maxilla and orofacial pain (odds ratio 2.19; 95% confidence in-
terval 1.19-4.02) (Figure S2, Table 2), whereas there was no such as-
sociation for impacted third molars in the mandible (odds ratio 1.33; 
95% confidence interval 0.74-2.37) (Figure S3). This association was 
more evident in the right upper jaw and independent of the age, 
gender, level of education and preferred chewing side. On the other 
hand, no significant associations of third molar status with migraine 
or other types of headache were found. There were no significant 
interactions of age or gender with impacted or missing third molars 
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on orofacial pain. We included caries and periodontal diseases as 
confounders in our analysis and found no differences.
4  | DISCUSSION
We investigated third molar status in a population-based sample 
and found a relatively strong association between impacted max-
illary third molars and orofacial pain. Interestingly, impacted third 
molars had no association with migraine or other types of headache. 
Although orofacial pain and its multifactorial causes and pathways 
have been extensively discussed in the literature, we found no previ-
ous studies that looked into this particular association.
Capitalizing on the large sample size and the representative char-
acter of this study, this is the first study to evaluate the association 
between third molars and orofacial pain using a combination of MRI 
diagnostics, questionnaires and clinical examinations. Our study 
sample was not recruited from a healthcare facility but rather ran-
domly drawn from public registries, and the findings are likely to be 
generalized. Studies based on patients do not represent the situa-
tion in the general population. High levels of quality assurance and 
the strict adherence to standardization of the examination methods 
and data management are other advantages. Third molar status is 
most frequently analysed through two-dimensional X-ray images, 
whereby participants are exposed to radiation. Using MRI images, 
we were able to analyse third molars without additional radiation 
exposure. Additionally, we excluded participants suffering pain upon 
two palpation methods of the temporomandibular joint (TMJ) and 
masticatory muscles. This aimed to limit the possible overlapping 
with pain caused by TMJ disorders. Pain information was collected 
based on a combination of subjective and objective data, improving 
data validity significantly.
Unfortunately, by the time of data collection, it was not pos-









Median age (25th, 75th 
percentile)
1808 61 (51; 69) 51 (42; 60) 47 (38; 61)
Sex 1808
Male 326 (48.5%) 423 (50.5%) 187 (62.5%)
Female 346 (51.5%) 414 (49.5%) 112 (37.5%)
Education 1805
Less than 10 y 187 (27.8%) 103 (12.3%) 35 (11.7%)
10 y 319 (47.5%) 509 (61.0%) 156 (52.2%)
More than 10 y 165 (24.6%) 223 (26.7%) 108 (36.1%)
Preferred chewing side 1802
None 336 (50.0%) 420 (50.4%) 171 (57.8%)
Left 123 (18.3%) 125 (15.0%) 42 (14.2%)
Right 213 (31.7%) 289 (34.7%) 83 (28.0%)
Orofacial pain 1808
No 628 (93.5%) 776 (92.7%) 273 (91.3%)
Yes 44 (6.6%) 61 (7.3%) 26 (8.7%)
Migraine 1825
No 617 (91.8%) 749 (89.6%) 277 (92.6%)
Yes 55 (8.2%) 87 (10.4%) 22 (7.4%)
Headache 1568
No 210 (37.1%) 248 (34.1%) 84 (32.7%)
Yes 356 (62.9%) 480 (65.9%) 173 (67.3%)
Periodontitis 1572
None or mild 198 (39.8%) 340 (43.1%) 138 (48.4%)
Moderate 199 (40.0%) 297 (37.6%) 102 (35.8%)
Severe 100 (20.1%) 153 (19.4%) 45 (15.8%)
Dental caries 1721
Mean DFS 17 (9; 25) 19 (12; 25) 15 (9; 24)
TA B L E  1   Third molar status 
by sociodemographic and clinical 
characteristics
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extractions or congenital absence. Moreover, partially erupted and 
impacted third molars were rather difficult to distinguish and thus 
might have biased our findings. The reason for pain medication in-
take by our participants is unknown. This called for the exclusion of 
participants taking NSAIDs, opioids or analgesics.
Woolf et al33 described four types of mechanism-based pain: no-
ciceptive, inflammatory, neuropathic and functional pain. This clas-
sification simplified the complexity of different mechanisms behind 
pain sensation and suggests a number of interpretations of our find-
ings. According to the International Association for the Study of Pain 
(IASP), ‘nociceptive pain arises from actual or threatened damage to 
non-neural tissue and is due to the activation of nociceptors’.34 Pain 
signals are transmitted through Aδ fibre and C-fibre. Aδ fibres are 
myelinated, fast-conducting and mostly found in superficial organs, 
whereas C-fibres are unmyelinated, slow-conducting and located in 
deeper organs such as the joints, muscles and bone.35 Activation of 
Aδ fibres results in sharp well localized pain, such as that accom-
panying a partially erupted tooth. C-fibres, on the other hand, are 
responsible for prolonged dull painful sensations that are character-
ized usually by poor localization, a common feature among patients 
complaining of orofacial pain.
Third molar agenesis has been long studied, with some genetic 
loci speculated to play a role.36 Many theories have been provided 
to explain the increasing rate of third molar agenesis and impaction 
through evolution, but this state is still controversial.37,38 Regardless 
of the reason for impaction, an impacted third molar could be re-
garded as a potentially harmful stimulus and cause nociceptive pain. 
We believe that our observed association of orofacial pain with miss-
ing third molars can be explained by post-traumatic neuropathy sec-
ondary to the surgical removal of said teeth. Chronic pain following 
common surgical procedures is known in the medical field but remains 
neglected in dentistry.39 Despite the fact that we were unable to dif-
ferentiate between congenitally missing third molars and surgically 
removed ones, the reported low prevalence of third molars agenesis 
among various populations favours our proposed explanation.
Inflammatory pain, on the other hand, is caused by the chemi-
cal inflammation mediators produced locally by damaged tissues or 
released by inflammation cells migrating through the blood stream. 
Impacted third molars are often accompanied by cystic changes. 
Previous studies sponsored by the American Association of Oral 
and Maxillofacial surgeons proposed that even asymptomatic 
impacted third molars might pose high risks for adjacent second 
molars through the localized progression of periodontal disease 
and caries; this in turn may provoke a chronic inflammatory pain 
response.40,41 However, in a previous study, we investigated the 
systemic effect of third molars on serum levels of inflammatory 
parameters and found no association.42 Nevertheless, local inflam-
mation due to either cystic changes around third molars or peri-
odontal disease (even under its subclinical threshold) might amplify 
existing nociceptive pain.
Moreover, the cortical bone in the maxilla tends to be thinner 
than that of the mandible (The thickest cortical bone can be found 
in the mandible in the premolar and molar regions). This gives the 
maxilla its porous, flexible and highly vascular nature, in contrast 
to the dense compact mandibular bone.43 Lower bone density has 
been reported in the tuberosity region, corresponding to the po-
sition of upper third molars. A higher vascularization rate reflects 
higher levels of nerve growth factor and the local cytokines that 
have been reported to be essential to the development of pain hy-
persensitivity.44 Anatomically, the mandible represents the lower 
movable part of the face and articulates with the skull only through 
the temporomandibular joint, serving as the attachment point for 
various masticatory muscles. On the other hand, the maxillae form 
TA B L E  2   Association of third molar status with pain
N (%)
Odds ratio 
(95% CI) P > |z|
Orofacial pain 121 (7.7%)
Molar 18
Missing 87 (8.4%) 1.80 (1.10, 2.96) 0.020
Impacted 12 (11.3%) 2.41 (1.14, 5.09) 0.021
Molar 28
Missing 89 (8.4%) 1.83 (1.10, 3.03) .020
Impacted 11 (9.9%) 2.11 (0.98, 4.56) .057
Molar 38
Missing 67 (7.6%) 1.07 (0.71, 1.63) .742
Impacted 14 (11.3%) 1.82 (0.94, 3.50) .074
Molar 48
Missing 68 (7.9%) 1.05 (0.70, 1.56) .822
Impacted 7 (5.7%) 0.77 (0.33, 1.76) .528
Maxilla
Missing 74 (8.5%) 1.74 (1.10, 2.75) .018
Impacted 18 (10.7%) 2.19 (1.16, 4.04) .015
Mandible
Missing 49 (7.5%) 0.99 (0.66, 1.49) .975
Impacted 16 (8.7%) 1.25 (0.69, 2.27) .460
Migraine 148 (9.4%)
Maxilla
Missing 85 (9.8%) 1.23 (0.83, 1.84) .302
Impacted 15 (8.9%) 1.10 (0.58, 2.08) .767
Mandible
Missing 63 (9.6%) 1.00 (0.69, 1.45) .986
Impacted 13 (7.0%) 0.79 (0.42, 1.51) .479
Headache 912 (67.1%)
Maxilla
Missing 489 (65.3%) 1.09 (0.83, 1.44) .524
Impacted 103 (72.0%) 1.34 (0.86, 2.10) .200
Mandible
Missing 378 (66.9%) 1.22 (0.94, 1.59) .136
Impacted 116 (71.2%) 1.34 (0.89, 2.03) .163
Note: Results are derived from logistic regression models adjusted for 
age, gender, educational status, preferred chewing side, periodontitis 
and caries with erupted third molars as reference category.
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the dominant portion of the face and are connected with a number 
of skull bones. The difference between the maxilla and the mandi-
ble in our findings may be attributed to those anatomical charac-
teristics. We detected a slight difference between the right and left 
side of the maxilla but this is unlikely to be important. We believe 
that complex associations among the previously mentioned mech-
anism-based pains, and the anatomical considerations of the upper 
and lower jaw are the underlying causes of orofacial pain from im-
pacted maxillary third molars.
When examining the causes of orofacial pain, physicians should 
keep pain referral in mind through the diagnosis procedure. The com-
plexity of the underlying anatomical structures and unpredictable pain 
referral mechanisms means that accurate diagnosis and proper man-
agement of orofacial pain disorders are a difficult challenge. A key point 
in orofacial pain diagnosis is to inspect and rule out all possible under-
lying causes which may have referred the pain to sites distant from the 
origin.45 The actual source of orofacial pain might be distant from the 
location described by patients. The intensity, duration and nature of 
pain should help differentiate pain origin as part of the initial diagnosis. 
Pain caused by TMD is very likely to overlap and be confused with 
third molar complaints. DeAngelis et al46 examined patients referred 
for third molar removal and suggested, on the contrary, that signs of 
TMD are common in patients referring for third molar removal. The 
guidelines of the American Academy of Orofacial Pain for assessment, 
diagnosis and management of orofacial pain and diagnostic criteria for 
temporomandibular disorders (DC/TMD) remain the gold standard for 
physicians differentiating both aetiologies.
The failure to diagnose and manage orofacial pain may lead 
to the development of chronic orofacial pain which in turn have a 
huge impact on patients' quality of life. Orofacial pain can prevent 
patients from performing their daily tasks and activities and led in 
some severe cases to depression.47,48 Besides, the high percentage 
of patients not seeking professional treatment reported by many 
studies amount to unnecessary financial burden for healthcare 
providers and the economic system due to lost working days.49,50 
Patients are usually unsure where to start their treatment, which 
emphasizes again the importance of multidisciplinary work and 
the essential need of a dental consult to rule out causes of oro-
facial pain of dental origin in general and impacted third molars in 
particular.
We have highlighted a number of explanations for orofacial pain 
caused by third molars and thus will be valuable for practitioners 
in their decision-making on third molar removal. Dentists should 
be more involved in managing orofacial pain because they are well 
acquainted with the various underlying structures of the orofacial 
region, bearing in mind possible consequences of removing third 
molars or choosing to opt for active surveillance. Risk-benefit evalu-
ation and possible complications associated with surgery should not 
be underestimated. An individual assessment for each patient with 
a pain complaint is essential for optimal care. Longitudinal studies 
focusing on orofacial pain and third molar occurrence are needed to 
confirm the associations reported here.
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Do Third Molars Contribute to
Systemic Inflammation? Results From
a Population-Based Study From
Northeast Germany
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Purpose: Erupted and impacted third molars have been reported to contribute to systemic inflamma-
tion. This study investigated the systemic effect of third molars on serum levels of inflammatory parame-
ters and on inflammatory messenger peptide hormones in a general population sample.
Materials and Methods: Data of 2,151 participants from the Study of Health in Pomerania were
included in this study. Erupted or impacted third molars were assessed with whole-body magnetic
resonance imaging at 1.5 T and associated with biomarkers of inflammation, lipid metabolism, glucose
metabolism, and peptide hormones by linear regression. Models were adjusted for age, gender, smoking
status, education, and type 2 diabetes mellitus.
Results: Neither erupted nor impacted third molars were associated with high-sensitivity C-reactive pro-
tein, white blood cell count, or fibrinogen as markers for systemic inflammation. Participants with erupted
third molars had markedly lower serum levels of leptin (b coefficient,!2.47; 95% confidence interval [CI],
!4.47 to!0.48), angiopoietin-2 (b coefficient,!135.1; 95% CI, 248.6 to!21.5), and ratio of angiopoietin-
2 to tyrosine kinase with immunoglobulin-like loop epidermal growth factor homology domain 2 (b coef-
ficient, !6.57; 95% CI, !13.06 to !00.7) than participants without third molars. No such associations
were observed for impacted third molars.
Conclusion: The present results did not substantiate a relation between third molars and an increase in
systemic inflammatorymarkers. Therefore, dental practitioners should be careful when considering this as
the only indication for removal of third molars, especially in medically compromised patients. The results
of this study showed that participants with erupted third molars had lower levels of messenger peptide
hormones, such as leptin and angiopoetin-2.
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Erupted and impacted third molars have been re-
ported to contribute to systemic inflammation.1,2
High-sensitivity C-reactive protein (hsCRP), leukocyte
counts, and fibrinogen are the most commonly used
inflammatory markers in clinical practice.3-5 Erupted
third molars were positively associated with serum
levels of CRP and interleukin-6 in 3 cross-sectional
population-based studies.1 Erupted third molars also
have been described as risk factors for increased peri-
odontal probing depths, which in turn, if found in the
third molar region,6-8 can induce localized
inflammation.1,8,9 This can lead to a systemic
manifestation of inflammation.10 Likewise, a higher
risk for increased probing depths and for periodontal
pathology has been described for asymptomatic
impacted third molars.8,11,12 Associations of chronic
apical periodontitis with increased hsCRP levels have
been reported.13 Dentigerous cysts developed by
liquid accumulation between the enamel epithelium
and the crown of impacted third molars also promote
local inflammation in the connective tissue.14,15 This
local inflammation is reported to lead to systemic
inflammation and can even cause sepsis.15
Graziani et al2 evaluated changes of systemic inflam-
matory markers after removal of impacted or semi-
impacted third molars in a small case-and-control study
with 40 patients. In that study, patients with impacted
or semi-impacted third molars had higher levels of CRP
and fibrinogen at baseline than the control group.
Therefore, they concluded that removal of semi-
impacted or impacted third molars would have benefi-
cial effects on systemic inflammation, suggesting that,
even without signs of a clinical infection, a low-grade
systemic inflammation is clinically relevant. Moss
et al10 deduced that women of child-bearing age
should be made aware of the systemic risks of oral
inflammation caused by third molars, which was indi-
cated by higher odds for preterm birth in women with
third molars. Furthermore, increased CRP levels are
associated with metabolic syndrome16 and are re-
ported to trigger the development of a proinflamma-
tory state, leading to atherothrombosis.16
In systemic inflammatory disorders, messenger pep-
tides, such as leptin, angiopoietin, and insulin-like
growth factor 1 (IGF-1), seem to play a role.17-19
Third molars have been locally associated with
leptin, angiopoietin, and IGF-1, but a systemicmanifes-
tation was not investigated.20-22 In a small study with
21 patients, the third molar group with inflamed
pulps expressed the locally increased messenger
peptide hormone, leptin, compared with controls
without inflamed pulps.20 Leptin is an important hor-
mone secreted by adipose tissue and is described as
a mediator of the inflammatory response.17 Similarly,
angiopoietin-1 and angiopoietin-2 (Ang-2) were ex-
pressed in tooth germs and ameloblastic tumors and
seemed to participate in tooth development and odon-
togenic tumor progression by regulating angiogen-
esis.21 In systemic inflammatory disorders, the
importance of the angiopoietin and tyrosine kinase
with immunoglobulin-like loop epidermal growth fac-
tor homology domain 2 (TIE-2) system has been
described in many studies.18 Not only does the
messenger peptide IGF-1 regulate the metabolism of
hard dental tissues through binding to the receptor
of odontoblasts, cementoblasts, and cell colonies in
the pulpal mesenchyme of third molars,22 but the
IGF system also seems to play a role in linking glucose
metabolism with systemic inflammation.19
The systemic effect of third molars is clinically rele-
vant for practitioners deciding whether to remove
third molars, especially in medically compromised pa-
tients. This study aimed to clarify the impact of erup-
ted and impacted third molars, diagnosed by
magnetic resonance imaging (MRI), on systemic
inflammation in a population-based sample.
Materials and Methods
The Study of Health in Pomerania (SHIP) is a
population-based cohort study in West Pomerania in
the northeastern region of Germany.23 In a random
cluster sample, participants 20 to 79 years old were
analyzed.24 At follow-up, 3,708 eligible participants
were re-invited for a second examination (SHIP-2;
2008 to 201223), in which 2,333 participated (follow-
up response, 62.9%). From 2008 to 2012, a second in-
dependent cohort (SHIP-Trend23) was established,
covering the same geographic recruitment region. Of
a stratified random sample of 8,826 adults 20 to
79 years old, 4,420 participated in SHIP-Trend
(response, 50.1%).25 The local ethics committee at
the University of Greifswald (Greifswald, Germany)
approved the study protocols (15.05.2008, BB 39/
08). The study was conducted in full accordance
with ethical principles, including the World Medical
Association’s Declaration of Helsinki, and written
informed consent was obtained from each participant.
The present study used pooled data of SHIP-2
(n = 2,333) and SHIP-Trend (n = 4,420).23 In SHIP-2
and SHIP-Trend, MRI26 examinations were conducted.
Of the 6,753 participants of SHIP-2 and SHIP-Trend,
data on third molars were available in 2,484. In 333 par-
ticipants, data on at least 1 laboratory marker were
missing, resulting in a study population of 2,151. Serum
levels of angiopoietin, angiopoietin receptor TIE-2, IGF-
1, IGF binding protein-3 (IGF-BP3), and leptin were
available in only a subset of this population.
Education and smoking status were assessed by
computer-assisted personal interviews. Education was
subdivided into 3 categories (<10, 10, and >10 yr).
Smoking was categorized as never, former, and current.
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All MRI examinations were performed in a 1.5-T
magnetic resonance scanner (Magnetom Avanto;
Siemens Medical Systems, Erlangen, Germany). The
imaging protocol was described elsewhere.26 For eval-
uation of third molars, transversal T1-weighted turbo
spin echo images (echo time [TE], 11 ms; repetition
time [TR], 587 ms; slice thickness, 4 mm; matrix,
256" 256) of the neck and sagittal T1-weighted turbo
spin echo images (TE, 120 ms; TR, 6,760 ms; slice
thickness, 4 mm; matrix, 448 " 448) of the cervical
spine, which included the maxilla and mandible,
were used. In addition, coronal oriented T2-
weighted fat-suppressed images (TR, 4,891 ms; TE,
670 ms; inversion time, 160 ms; slice thickness,
5 mm) were available. For third molar analysis, MR im-
ageswere transferred to awork station (Mac OSX), and
OsiriX 3.8.1 software (Pixmeo, Geneva, Switzerland)
was used for analysis. Third molar analysis was per-
formed by 2 trained dentists (P.S. and S.H.). Interob-
server agreement k values for third molar
assessments ranged from 0.90 to 0.94 for the maxilla
and from 0.81 to 0.83 for the mandible. In cases with
disagreement, the assessment of the dentist with
more radiologic experience and more involvement in
the development of the protocol (P.S.) was used.
Image analysis of third molars was conducted with a
predefined algorithm. Axial and sagittal images were
displayed simultaneously, and the cross-referencing
tool of OsiriX was used for exact anatomic correla-
tions. For adequate third molar analysis, sagittal images
were zoomed. On axial images, the number of teeth
was counted for each quadrant, and the molars were
identified. The levels defined by Pell and Gregory27
were used to classify existing third molars of the
mandible and maxilla. A 3-category classification for
third molars resulted: 1) nonexistent third molar; 2)
erupted but not impacted third molar; and 3) at least
1 impacted third molar. In addition, upper third molars
were evaluated as localized in the maxillary sinus if at
least 50% of an impacted third molar was located in the
maxillary sinus.
Blood samples were taken after a fast from 7 AM to
2 PM and analyzed in the central laboratory of the Uni-
versity Medicine Greifswald. Fasting blood samples
were drawn from the cubital vein in the supine posi-
tion, and serum aliquots were prepared for immedi-
ate analysis and storage at !80#C. Ang-2 and
soluble TIE-2 (sTIE-2) levels were measured in serum
using commercially available assays (R&D Systems,
Minneapolis, MN) using 3 different lots in the 2 study
populations. The minimum detectable dose was 1.20
pg/mL for Ang-2 and 0.001 ng/mL for sTIE-2. Fibrin-
ogen concentrations were determined in citrate
plasma according to Clauss using a BCS-XP system
(Siemens Healthcare Diagnostics, Eschborn, Ger-
many).28 White blood cell concentrations were
measured within 60 minutes on a Sysmex XT-2000
analyzer (Siemens AG, Munich, Germany) in SHIP-
Trend. HsCRP concentrations were measured using
the Dimension VISTA 500 analytical system (Siemens
AG). Photometry (Dimension VISTA; Siemens Health-
care Diagnostics) was used to measure total choles-
terol, total triglyceride, and serum glucose
concentrations. High-density lipoprotein (HDL) and
low-density lipoprotein cholesterol were selectively
precipitated and then determined by homogenous
assays (Dimension VISTA). Serum leptin concentra-
tions (Mediagnost, Reutlingen, Germany) were
measured using the enzyme-linked immunosorbent
assay technique. Glycated hemoglobin (HbA1c) was
determined by high-performance liquid chromatog-
raphy (Bio-Rad, Munich, Germany).29
Stratified by third molar status, continuous data
were described by medians and 25th and 75th percen-
tiles and categorical data were described by absolute
numbers and percentages. Linear regression models
adjusted for age, gender, smoking status, and educa-
tion and weighted for dropout from MRI examinations
were used to associate third molar status with labora-
tory biomarker levels, with no third molars as the
reference category. A P value less than .05 was defined
as statistically significant. All analyses were conducted
with STATA 14.1 (Stata Corporation, College
Station, TX).
Results
Participants without third molars were older than
those with erupted or impacted third molars
(Table 1). Impacted third molars were more often
observed in men than in women, whereas women
more frequently had erupted third molars than men.
Median serum levels of leptin and Ang-2 were lower
in participants without third molars than in those
with erupted or impacted third molars. Median levels
of IGF-1 and IGF-BP3 were highest in participants with
impacted third molars.
In multivariable linear regression adjusted for age,
gender, smoking status, education, and type 2 diabetes
mellitus, no relevant associations were observed be-
tween third molars and inflammatory or lipid markers.
A sensitivity analysis stratified for periodontitis was
performed, but no effect on hsCRP was discovered
in the group with periodontitis or the group without
periodontitis. Participants with third molars had
notably lower levels of HbA1c, leptin, Ang-2, and
Ang-2/TIE ratio than those without third molars,
whereas no such associations were observed for
impacted third molars (Table 2). Associations of
impacted third molars with IGF-1 and IGF-BP3 levels
barely missed statistical relevance (Table 2).
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Discussion
Neither erupted nor impacted third molars were
associated with signs of a systemic inflammation in
the general population. Associations of impacted third
molars with the IGF system barely missed statistical
relevance. Participants with erupted third molars had
considerably lower serum levels of HbA1c, leptin,
Ang-2, and Ang-2/TIE ratio than those without third
molars. No such associations were observed for
impacted third molars.
In contrast to previous studies,1,2,10 no relevant
association between third molar status and
inflammatory markers was found in the present
study. Offenbacher et al1 described an association of
an increased probing depth in the distal sites of adja-
cent second molars with increased serum levels of
interleukin-6 and CRP. The authors previously investi-
gated the association between third molars and
periodontal damage of adjacent second molars as a po-
tential manifestation of local inflammation and found
relevant associations in the mandible.8 Calibrated
and licensed dentists clinically measured probing
depth and clinical attachment level with a periodontal
probe. In the present analyses, no relevant association
of third molar status with hsCRP levels was found in
participants with periodontitis or in participants
without periodontitis.
Methodologic differences could explain the
discrepant findings between the present study and
previous studies. In the study by Offenbacher et al,1
impacted third molars were not evaluated by
Table 1. STUDY CHARACTERISTICS STRATIFIED BY THIRD MOLAR STATUS
n No Third Molars (n = 695)
Erupted Third Molars
(n = 1,054)
$1 Impacted Third Molar
(n = 402)
Age (yr) 2,151 56 (45; 66) 50 (42; 59) 46 (38; 59)
Men 2,151 301 (58.7) 498 (47.3) 238 (59.2)
Current smokers 2,151 134 (19.3) 229 (21.8) 87 (21.6)
Type 2 diabetes 2,151 55 (8.0) 63 (6.1) 27 (6.8)
Education 2,117
Low 146 (21.2) 121 (11.7) 47 (11.9)
Median 352 (51.2) 619 (59.9) 212 (53.7)
High 190 (27.6) 294 (28.4) 136 (34.4)
Waist circumference (cm) 2,151 89.3 (79.5; 99.0) 88.9 (80.0; 97.8) 89.0 (78.9; 98.0)
hsCRP (mg/L) 2,079 1.17 (0.64; 2.45) 1.13 (0.61; 2.39) 1.05 (0.57; 2.38)
Fibrinogen (Clauss; g/L) 2,151 3.0 (2.5; 3.5) 3.0 (2.4; 3.4) 2.8 (2.4; 3.4)
White blood cell count
(Gpt/L)
2,151 5.8 (4.9; 6.8) 5.6 (4.8; 6.8) 5.6 (4.7; 6.7)
Glucose (mmol/L) 2,151 5.3 (4.9; 5.9) 5.3 (4.9; 5.8) 5.3 (4.9; 5.8)
HbA1c (%) 2,151 5.3 (5.0; 5.7) 5.2 (4.9; 5.6) 5.2 (4.8; 5.5)
Total cholesterol (mmol/L) 2,151 5.4 (4.7; 6.1) 5.5 (4.8; 6.3) 5.3 (4.6; 6.1)
LDL cholesterol (mmol/L) 2,151 3.3 (2.8; 3.9) 3.4 (2.7; 4.0) 3.3 (2.7; 3.9)
HDL cholesterol (mmol/L) 2,151 1.4 (1.2; 1.7) 1.4 (1.2; 1.7) 1.4 (1.2; 1.6)
Triglycerides (mmol/L) 2,151 1.4 (1.0; 2.0) 1.4 (0.9; 2.0) 1.3 (0.9; 2.0)
Leptin (ng/mL) 759 12.4 (7.0; 23.5) 10.1 (5.7; 18.8) 7.6 (4.5; 13.4)
IGF-1 (ng/mL) 759 134 (103; 169) 142 (118; 174) 157 (120; 186)
IGF binding protein-3
(ng/mL)
759 4,097 (3,450; 4,763) 4,267 (3,731; 4,852) 4,343 (3,688; 5,106)
Angiopoietin-2 (pg/mL) 1,443 1,854 (1,424; 2,473) 1,722 (1,370; 2,248) 1,690 (1,246; 2,109)
Angiopoietin receptor
TIE-2 (ng/mL)
1,443 18.0 (15.4; 21.1) 18.1 (15.6; 21.1) 18.5 (16.0; 21.9)
Angiopoietin-to-TIE ratio 1,443 106 (78; 141) 95 (73; 125) 89 (66; 120)
Periodontitis 2,151
None or mild 959 287 (41.3) 473 (44.9) 199 (49.5)
Moderate or severe 1,192 408 (58.7) 581 (55.1) 203 (50.5)
Note: Data are expressed as median (25th percentile; 75th percentile) for continuous data or as absolute number (percentage)
for categorical data.
Abbreviations: HbA1c, glycated hemoglobin; HDL, high-density lipoprotein; hsCRP, high-sensitivity C-reactive protein; IGF,
insulin-like growth factor; LDL, low-density lipoprotein; TIE-2, tyrosine kinase with immunoglobulin-like loop epidermal growth
factor homology domain 2.
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radiographic imaging or MRI. The present findings also
differ from the comparative study of Graziani et al2 in
which participants with impacted or semi-impacted
third molars had higher levels of CRP and fibrinogen
at baseline than the control group. Therefore, Graziani
et al concluded that third molar removal could have
beneficial systemic effects. Selection bias could
explain the discrepant results in the present study.
Graziani et al2 primarily investigated the influence of
third molar removal on systemic inflammation in 18
patients with semi-impacted third molars and only 2
patients with impacted third molars who were
referred to the Department of Dentistry and Oral Sur-
gery of the University of Pisa (Pisa, Italy) for third
molar removal. Conversely, in the present study, a
possible misclassification between partially erupted
and impacted third molars by MRI could have
occurred.8 However, no association with inflamma-
tory parameters was discovered for impacted or erup-
ted third molars. Aspects of the study design, such as
selection of participants, might have had an impact
on differing findings. The strengths of the SHIP are
the population-based design, the high level of quality
assurance, the use of MRI, and strict adherence to stan-
dardization of examination methods and data manage-
ment.23 Two trained dentists, who strictly adhered to
the standardization, performed the MRI protocol
developed for analyzing third molars. Taken together,
high-quality data standards were consistently assured.
Limitations to the study also must be considered. Ac-
cording to quality guidelines of the federal committee
onMRI (Gemeinsamer Bundesausschuss), a slice thick-
ness of 5 mm is recommended for head and neck diag-
nostics.30 This study used a 4-mm slice thickness, and
the gap between 2 slices was 10%. Therefore, it was
not possible to differentiate between soft tissue and
bony impaction of third molars.11 This also could
have led to misclassification between partially erupted
and impacted third molars, which could have influ-
enced the present results. To detect third molars in a
whole-body MRI, the use of a 3-dimensional MR data-
set with dental reconstructions perpendicular to the
mandible and maxilla might have increased diagnostic
yield. However, the observer agreement for third
molar assessment was very good.
In contrast to Graziani et al2 who described an as-
sociation of impacted third molars with triglycer-
ides, HDL cholesterol, and glucose, the authors
Table 2. LINEAR REGRESSION RESULTS EVALUATING CROSS-SECTIONAL ASSOCIATIONS BETWEEN THIRD MOLAR
STATUS AND SEVERAL BIOMARKERS
Model 1 Model 2
$1 Third Molar Available* Erupted Third Molars* $1 Impacted Third Molar*
Waist circumference (cm) 0.65 (!0.52 to 1.82) 0.61 (!0.61 to 1.84) 0.74 (!1.00 to 2.48)
hsCRP (mg/L) !0.17 (!0.77 to 0.43) !0.21 (!0.86 to 0.44) !0.06 (!0.69 to 0.56)
Fibrinogen (Clauss; g/L) 0.03 (!0.06 to 0.11) 0.01 (!0.08 to 0.10) 0.08 (!0.03 to 0.19)
White blood cell count
(Gpt/L)
0.00 (!0.23 to 0.23) !0.01 (!0.22 to 0.20) 0.03 (!0.38 to 0.44)
Glucose (mmol/L) !0.03 (!0.24 to 0.18) !0.07 (!0.26 to 0.12) 0.07 (!0.29 to 0.42)
HbA1c (%) !0.10 (!0.18 to !0.01)y !0.10 (!0.18 to !0.02)y !0.08 (!0.21 to 0.04)
Total cholesterol (mmol/L) 0.09 (!0.02 to 0.21) 0.12 (!0.01 to 0.24) 0.03 (!0.14 to 0.21)
LDL cholesterol (mmol/L) 0.06 (!0.03 to 0.16) 0.07 (!0.03 to 0.18) 0.04 (!0.11 to 0.19)
HDL cholesterol (mmol/L) 0.02 (!0.02 to 0.06) 0.02 (!0.01 to 0.06) 0.00 (!0.05 to 0.05)
Triglycerides (mmol/L) !0.00 (!0.13 to 0.12) !0.03 (!0.16 to 0.11) 0.05 (!0.15 to 0.25)
Leptin (ng/mL) !2.47 (!4.47 to !0.48)y !2.73 (!4.84 to !0.63)y !1.72 (!4.09 to 0.65)
IGF-1 (ng/mL) 4.26 (!2.45 to 10.97) 2.80 (!4.12 to 9.73) 8.51 (!1.34 to 18.36)
IGF binding protein-3
(ng/mL)
100.8 (!47.2 to 248.7) 69.0 (!84.0 to 221.9) 193.6 (!15.7 to 403.0)
Angiopoietin-2 (pg/mL) !130.1 (!241.6 to !18.5)y !135.1 (!248.6 to !21.5)y !115.5 (!283.2 to 52.2)
TIE-2 (ng/mL) !0.15 (!0.71 to 0.40) !0.20 (!0.78 to 0.37) !0.00 (!0.77 to 0.76)
Angiopoietin-to-TIE ratio !6.53 (!13.05 to !0.02)y !6.57 (!13.06 to !0.07)y !6.43 (!17.31 to 4.45)
Note: All regression models were adjusted for age, gender, smoking status, education, and diagnosed type 2 diabetes mellitus and
weighted for dropout. Data are presented as b coefficient (95% confidence interval).
Abbreviations: HbA1c, glycated hemoglobin; HDL, high-density lipoprotein; hsCRP, high-sensitivity C-reactive protein; IGF,
insulin-like growth factor; LDL, low-density lipoprotein; TIE-2, tyrosine kinase with immunoglobulin-like loop epidermal growth
factor homology domain 2.
* Compared with no third molar.
y P < .05.
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could not confirm such associations; similarly, the
authors did not find an association of impacted third
molars with increased levels of cholesterol and HDL
cholesterol. Unexpectedly, the authors detected an
inverse association of erupted third molars with lep-
tin. Leptin is secreted by adipocytes, acts in the
hypothalamus to suppress appetite and food intake,
and regulates body weight.17,31 Serum leptin
concentrations have been positively related to
obesity and metabolic syndrome.32 Leptin is a medi-
ator of the inflammatory response, produces proin-
flammatory cytokines in obesity,33 and has a
proinflammatory effect in the immune system.20 In
the present study, participants with erupted third
molars had the lowest concentrations of leptin.
This inverse association could be connected to the
crucial role of teeth development for digestion in
evolution. The masticatory benefits of food process-
ing and carnivorous selection could be reasons for
the evolution of smaller teeth and jaws.34 Consistent
with these findings, Um et al35 postulated that leptin
could act as an important modulator of dental
mesenchymal stem cells and would have a promot-
ing effect on cemento-blastic and odontoblastic dif-
ferentiation. Impaction or eruption of third molars
could be linked with leptin serum levels in a kind
of negative feedback mechanism. The authors also
found that participants with third molars had lower
serum levels of Ang-2 than participants without
third molars. The angiopoietin and TIE system and
the release of Ang-2 have relevance in systemic in-
flammatory disorders by regulating inflammation.18
However, the authors cannot explain the inverse as-
sociations of third molars with the angiopoietin and
TIE system.
The results did not substantiate a relation between
third molars and an increase in systemic inflammatory
markers. Therefore, dental practitioners should be
careful when considering this as the only indication
for third molar removal, especially in medically
compromised patients. The authors found that partic-
ipants with erupted third molars had lower levels of
messenger peptide hormones, such as leptin and
Ang-2, compared with patients without third molars.
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